Organisation/Company Università degli studi di Brescia Research Field Medical sciences » Medicine Researcher Profile Recognised Researcher (R2) Leading Researcher (R4) First Stage Researcher (R1) Established Researcher (R3) Application Deadline 1 Dec 2026 - 14:00 (UTC) Country Italy Type of Contract To be defined Job Status Not Applicable Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research Infrastructure? No
Offer Description B-cell non-Hodgkin lymphomas (B-NHL), including diffuse large B-cell lymphoma (DLBCL) and Burkitt lymphoma (BL), are aggressive malignancies frequently driven by c-MYC. Despite current therapies, relapse remains common, highlighting the need for novel strategies. Our data indicate that FGF/FGFR signaling stabilizes c-MYC and that its inhibition induces c-MYC proteasomal degradation. We hypothesize that FGF/FGFR blockade may impair c-MYC-driven B-NHL growth and dissemination. Using FGF trapping and FGFR inhibitors, we will investigate the biological and molecular effects of FGF/FGFR blockade in DLBCL and BL in vitro and in vivo, assess its therapeutic efficacy alone or combined with R-CHOP, and develop novel FGF-trap molecules. This study may establish FGF/FGFR signaling as a novel therapeutic vulnerability in aggressive c-MYC-driven B-NHL
The evaluation criteria are established in the call; a master's degree obtained no more than six years ago is required; knowledge of Italian and English is required. The preferred professional competence for the collaboration to be established will concern experience in: cellular biology, molecular biology, lymphoma biology, study of the tumor microenvironment, study of angiogenesis processes, study of intracellular molecular pathways, and in vivo models of experimental oncology.
OTHER
Eligibility of fellows: country/ies of residence:
OTHER
Eligibility of fellows: nationality/ies:
OTHER
Selection process Public notice for the direct approval of a research position pursuant to Article 22-ter, paragraph 4, of Law No. 240/2010, a.d. MEDS-02/A “Experimental Medicine and Pathophysiology"
Blocking the FGF/FGFR system as a new therapeutic strategy for c-Myc-driven aggressive B-cell non-Ho in Rome datore di lavoro: Italian Ministry of Education, University and Research
L'Università degli Studi di Roma Tor Vergata offre un ambiente di lavoro stimolante e collaborativo, ideale per i ricercatori che desiderano contribuire a metodologie innovative nel campo della geotecnica. Con opportunità di crescita professionale e accesso a risorse all'avanguardia, i dipendenti possono sviluppare le proprie competenze in un contesto accademico di eccellenza, immerso nella vibrante cultura di Roma.
Dettagli di contatto:
Team di recruiting di Italian Ministry of Education, University and Research